InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2026-01-23 | Thomas H. Kean(R-NJ07) | house | Sale | $15,001 - $50,000 |
| 2025-12-10 | Gilbert Cisneros(D-CA31) | house | Purchase | $1,001 - $15,000 |
| 2025-11-20 | Thomas H. Kean(R-NJ07) | house | Sale | $15,001 - $50,000 |
| 2025-11-18 | Gilbert Cisneros(D-CA31) | house | Purchase | $1,001 - $15,000 |
| 2025-10-17 | Gilbert Cisneros(D-CA31) | house | Purchase | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net sales | $25.12B+11.2% | $22.59B+10.2% | $20.50B+11.1% | $18.45B+7.8% | $17.11B |
| Cost of sales | $9.05B+11.0% | $8.15B+9.6% | $7.44B+8.3% | $6.87B+11.9% | $6.14B |
| Gross profit | $16.07B+11.3% | $14.44B+10.6% | $13.06B+12.8% | $11.58B+5.6% | $10.97B |
| Research, development and engineering expenses | $1.62B+10.7% | $1.47B+5.6% | $1.39B-4.5% | $1.45B+17.7% | $1.24B |
| Selling, general and administrative expenses | $8.65B+12.6% | $7.68B+8.1% | $7.11B+11.4% | $6.39B-0.6% | $6.43B |
| Amortization of intangible assets | $732.0M+17.5% | $623.0M-1.9% | $635.0M+1.3% | $627.0M+1.3% | $619.0M |
| Goodwill and other impairments | $170.0M-82.6% | $977.0M+2613.9% | $36.0M-86.7% | $270.0M | — |
| Total operating expenses | $11.18B+4.0% | $10.75B+17.2% | $9.17B+5.0% | $8.74B+4.2% | $8.38B |
| Operating income | $4.89B+32.5% | $3.69B-5.1% | $3.89B+36.9% | $2.84B+9.9% | $2.58B |
| Interest expense | -$607.0M-48.4% | -$409.0M-12.7% | -$363.0M | — | — |
| Other income | $232.0M+9.4% | $212.0M+43.2% | $148.0M | — | — |
| Earnings before income taxes | $4.51B+29.3% | $3.49B-4.9% | $3.67B+36.9% | $2.68B+17.6% | $2.28B |
| Income taxes | $1.27B+154.1% | $499.0M-1.8% | $508.0M+56.3% | $325.0M+13.2% | $287.0M |
| Net earnings | $3.25B+8.5% | $2.99B-5.4% | $3.17B+34.2% | $2.36B+18.3% | $1.99B |
| Basic net earnings per share of common stock (in dollars per share) | $8.5M+8.0% | $7.9M-5.8% | $8.3M+33.9% | $6.2M+117669.4% | $5K |
| Diluted net earnings per share of common stock (in dollars per share) | $8.4M+8.2% | $7.8M-5.9% | $8.3M+33.7% | $6.2M+118326.1% | $5K |
| Basic (in shares) | $382.2M+0.3% | $381.0M+0.4% | $379.6M+0.4% | $378.2M+100218.3% | $377K |
| Effect of dilutive employee stock compensation (in shares) | $4.3M-6.5% | $4.6M+12.2% | $4.1M+2.5% | $4.0M+75371.7% | $5K |
| Diluted (in shares) | $386.5M+0.2% | $385.6M+0.5% | $383.7M+100292.5% | $382K-0.0% | $382K |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Stryker maintains 2026 outlook of 8%-9.5% organic sales growth and $14.90-$15.10 adjusted EPS amid cyber incident recovery
Stryker Corporation (SYK) Q1 2026 Press Conference Call Transcript
Stryker in rare double earnings miss; maintains 2026 guidance
Stryker (SYK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates